Development of Benzodiazepine and Picrotoxin (t-Butylbicyclophosphorothionate) Binding Sites in Rat Cerebellar Granule Cells in Culture
- 1 February 1990
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 54 (2) , 473-478
- https://doi.org/10.1111/j.1471-4159.1990.tb01896.x
Abstract
The specific bindings of [3H]flunitrazepam ([3H]FLU), [3H]CGS 8216, and t-[35S]butylbicyclophosphorothionate ([35S]TBPS) to sites on rat cerebellar granule cells all increase from 4 to 15 days in culture, altough their time courses differ. Specific [3H]FLU binding doubles, [3H]CGS 8216 binding triples, and [35S]TBPS binding increases about fourfold from 4 to 15 days in culture. Displacement studies, using the type I-selective ligand CL 218,872, indicate that at 4 days the [3H]FLU binding sites are almost entirely "type II," judging from an IC50 value near 300 nM and a pseudo-Hill number near 1. By 10 days, approximately equal numbers of type I and type II binding sites are present in the cultured cells, and this ratio remains constant thereafter (12 and 15 days). At days 10-15, both the IC50 value for CL 218,872 (near 100 nM) and the pseudo-Hill number (near 0.7) remain constant and are significantly different from the values at culture day 4. The development of specific [35S]TBPS binding parallels that of [3H]CGS 8216 binding more closely than the development of [3H]FLU binding. The [3H]CGS 8216/[3H]FLU ratio increased by a factor of 1.6 from day 4 to day 15 (p < 0.001). Taken together, our data suggest that the existence of several .gamma.-aminobutyric acidA (GABAA) receptor subunits, the relative proportions of which change during development. The presence of the GABA-minetic 4,5,6,7-tetrahydroisoxazolo[5,4c]pyridine-3-ol [THIP] in the culture medium had no apparent effect on any of the binding sites studied, although THIP was shown previously to induce low-affinity GABA binding sites.Keywords
This publication has 37 references indexed in Scilit:
- Receptor structure: the accelerating impact of molecular biologyTrends in Pharmacological Sciences, 1989
- Structural and functional basis for GABAA receptor heterogeneityNature, 1988
- Monoclonal antibodies reveal structural homogeneity of gamma-aminobutyric acid/benzodiazepine receptors in different brain areas.Proceedings of the National Academy of Sciences, 1985
- The development of Type I and Type II benzodiazepine receptors in the mouse cortex and cerebellumPharmacology Biochemistry and Behavior, 1985
- GABA receptor multiplicity: Visualization of different receptor types in the mammalian CNSNeuropharmacology, 1984
- CGS 8216: Receptor binding characteristics of a potent benzodiazepine antagonistLife Sciences, 1982
- Differential ontogeny of Type 1 and Type 2 benzodiazepine receptorsLife Sciences, 1981
- A steroid derivative, R 5135, antagonizes the GABA/benzodiazepine receptor interactionNeuropharmacology, 1981
- Resolution of two biochemically and pharmacologically distinct benzodiazepine receptorsPharmacology Biochemistry and Behavior, 1979
- Ontogenetic development of benzodiazepine receptors in the rat brainBrain Research, 1978